Acute stress and nicotine cues interact to unveil locomotor arousal and activity-dependent gene expression in the prefrontal cortex.

Biological Psychiatry
Craig A SchiltzCharles F Landry

Abstract

This study examines the interactive effects of acute stress and nicotine-associated contextual cues on locomotor activity and activity-dependent gene expression in subregions of the prefrontal cortex. Locomotor activity of rats was measured in a context associated with either low-dose nicotine or saline administration with or without 5 minutes of pre-exposure to ferrets, a nonphysical stressor. After 45 minutes in the test environment, plasma corticosterone levels and mRNA levels of the immediate-early genes Arc, NGFI-B, and c-Fos in prefrontal and primary motor cortical subregions were measured. Stress alone increased plasma corticosterone and prefrontal cortex gene expression. Low-dose nicotine cues had no effect on corticosterone levels nor did they elicit conditioned motor activation, and they caused minor elevations in gene expression. Stress and low-dose nicotine cues, however, interacted to elicit conditioned motor activation and further increases in early response gene expression in prefrontal but not in the primary motor cortical subregions. Stress interacts with nicotine-associated cues to uncover locomotor arousal, a state associated with prefrontal neuronal activation and immediate early gene expression. Thus, in ni...Continue Reading

References

Feb 1, 1985·Pharmacology, Biochemistry, and Behavior·P J FudalaE T Iwamoto
Nov 1, 1986·Pharmacology, Biochemistry, and Behavior·P J Fudala, E T Iwamoto
Feb 1, 1970·The British Journal of Social and Clinical Psychology·A C McKennell
Jan 1, 1983·Addictive Behaviors·J E RoseM E Jarvik
Sep 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·D J Calcagnetti, M D Schechter
Sep 1, 1995·Addictive Behaviors·A DroungasC P O'Brien
Oct 20, 1998·Journal of Neurobiology·S Finkbeiner, M E Greenberg
May 14, 1999·Current Opinion in Neurobiology·P W Kalivas, M Nakamura
Mar 29, 2001·Pharmacology, Biochemistry, and Behavior·R A BevinsK S Pickett
Feb 14, 2002·Pharmacology, Biochemistry, and Behavior·A R CaggiulaA F Sved
Oct 29, 2002·Psychopharmacology·Yavin ShahamJane Stewart
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brock E SchroederAnn E Kelley
Mar 12, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M St-HilaireC Rouillard
Jul 5, 2003·Behavioural Brain Research·Rick A Bevins, Matthew I Palmatier
Feb 20, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Krista McFarlandPeter W Kalivas
Mar 6, 2004·Nature Neuroscience·Stephen J WilsonJulie A Fiez
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Zul MeraliHymie Anisman
Jul 9, 2004·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Werner G K StritzkeAlan R Lang
Jul 23, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Rita A FuchsRonald E See
Jan 22, 2005·Current Opinion in Pharmacology·Friedbert Weiss
Feb 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Victor Ramírez-AmayaCarol A Barnes
Mar 12, 2005·Science·Philippe N ToblerWolfram Schultz
Mar 15, 2005·Psychopharmacology·Bernard Le Foll, Steven R Goldberg
Mar 16, 2005·Behavioural Pharmacology·S V Mahler, H de Wit

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.